Details
|
Abgenix incorporation is a biopharmaceutical industry, which is focusing on discovering, developing, and manufacturing of therapeutic human antibodies used to treat different disease conditions, such as metabolic disorders, inflammation, and cancer. Company's antibody products include ABX-PTH -an therapeutic human antibody product candidate indicated for the secondary hyperparathyroidism treatment(works against parathyroid hormone); and ABX-EGF(Panitumumab) - the fully human antibody product indicated for the treatment of different solid tumors(works against epidermal growth factor receptors). Abgenics, inc. is collaborating with AstraZeneca UK Limited for the producing of therapeutic antibodies; and is having development agreement with such companies as Sosei Co., Chugai Pharmaceuticals, co., Dendreon co., Microscience Limited, and U3 Pharma AG. Abgenics is located in Fremont, state California and is trading on NASDAQ under symbol ABGX. Contact: www.abgenix.com
|
